On the effects of psychostimulants, antidepressants, and the antiparkinsonian drug levodopa on dopamine neurons
- PMID: 17105928
- DOI: 10.1196/annals.1369.029
On the effects of psychostimulants, antidepressants, and the antiparkinsonian drug levodopa on dopamine neurons
Abstract
The dopaminergic system constitutes the principal target of many psychostimulants, antidepressant, and antiparkinsonian drugs. The effects caused by these compounds are partly associated with an increased dopamine (DA) levels within the terminal areas of DA neurons and in the ventral midbrain. Therefore, several substances of abuse, antidepressants, and endogenous compounds (levodopa and trace amines [TAs]) regulate the activity of DA cells by activating D2 autoreceptors located on the terminals, soma, and dendrites. Considering our past and recent experimental studies on this issue, here we will briefly reexamine the mechanisms of action of several psychoactive drugs on DA neurons. In particular, we propose three different modalities by which the mesencephalic DA neurons can be regulated by drugs: amphetamine/TAs-like, cocaine-like, and levodopa-like. We, therefore, discuss the potential therapeutic and addictive properties of the psychoactive substances.
Similar articles
-
Differential effects of dopamine and psychoactive drugs on dopamine transporter phosphorylation and regulation.Neuropharmacology. 2005 Nov;49(6):759-68. doi: 10.1016/j.neuropharm.2005.08.011. Epub 2005 Sep 21. Neuropharmacology. 2005. PMID: 16181646
-
Electrophysiologic changes in ventral midbrain dopaminergic neurons resulting from (+/-) -3,4-methylenedioxymethamphetamine (MDMA-"Ecstasy").Biol Psychiatry. 2007 Sep 15;62(6):680-6. doi: 10.1016/j.biopsych.2006.11.019. Epub 2007 May 23. Biol Psychiatry. 2007. PMID: 17511969
-
Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.J Neurochem. 2009 Nov;111(4):1042-50. doi: 10.1111/j.1471-4159.2009.06381.x. Epub 2009 Sep 16. J Neurochem. 2009. PMID: 19765187
-
The midbrain slice preparation. An in vitro model to select potential anti-parkinsonian drugs?Parkinsonism Relat Disord. 2008;14 Suppl 2:S150-3. doi: 10.1016/j.parkreldis.2008.04.020. Epub 2008 Jun 25. Parkinsonism Relat Disord. 2008. PMID: 18583176 Review.
-
The dopamine transporter: a vigilant border control for psychostimulant action.Handb Exp Pharmacol. 2006;(175):215-32. doi: 10.1007/3-540-29784-7_11. Handb Exp Pharmacol. 2006. PMID: 16722238 Review.
Cited by
-
The Neurometabolic Function of the Dopamine-Aminotransferase System.Metabolites. 2025 Jan 6;15(1):21. doi: 10.3390/metabo15010021. Metabolites. 2025. PMID: 39852364 Free PMC article. Review.
-
Pharmacogenetics of antidepressant response.J Psychiatry Neurosci. 2011 Mar;36(2):87-113. doi: 10.1503/jpn.100059. J Psychiatry Neurosci. 2011. PMID: 21172166 Free PMC article. Review.
-
Restorative effect of endurance exercise on behavioral deficits in the chronic mouse model of Parkinson's disease with severe neurodegeneration.BMC Neurosci. 2009 Jan 20;10:6. doi: 10.1186/1471-2202-10-6. BMC Neurosci. 2009. PMID: 19154608 Free PMC article.
-
Protein Metabolism Changes and Alterations in Behavior of Trace Amine-Associated Receptor 1 Knockout Mice Fed a High-Fructose Diet.Neurol Int. 2023 Feb 28;15(1):339-351. doi: 10.3390/neurolint15010022. Neurol Int. 2023. PMID: 36976665 Free PMC article.
-
Blood-based biomarkers predicting response to antidepressants.J Neural Transm (Vienna). 2019 Jan;126(1):47-63. doi: 10.1007/s00702-018-1844-x. Epub 2018 Jan 27. J Neural Transm (Vienna). 2019. PMID: 29374800 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous